Published March 9, 2023 | Version v1
Publication Open

Serological surveillance on potential Plasmodium vivax exposure risk in a post-elimination setting

  • 1. Shanghai Municipal Center For Disease Control Prevention
  • 2. National Institute for Parasitic Diseases

Description

China was declared malaria free in June of 2021. In the post-elimination setting, vigilant surveillance is essential to sustain malaria free status. Serological surveillance has been recognized as an efficient tool for assessing the immunity levels and exposure risk in a population. In this study, a cross-sectional serological survey was conducted in Yingjiang County, China, in August-September, 2021. The study sites were villages along the borders with Myanmar, which have no local transmission since the last indigenous case registered in 2016. A total of 923 participants from six villages were enrolled. The majority was aged > 36 years (56.12%) and 12.46% (115/923) participants had experienced malaria infection at least once. A magnetic- bead-based assay was used to test antibodies against Plasmodium vivax antigen PvMSP-119 to evaluate the prevalence of antibody positive subjects. A reversible catalytic model was used to assess the risk of exposure. The prevalence of anti-PvMSP-119 IgG was 12.84% [95% confidence interval (CI): 9.22%-16.47%], 13.93% (95% CI: 10.11%-17.74%), and 3.57% (95% CI: 1.40%-5.75%) in three different line-of-defense areas, which differed significantly (P < 0.0001). The prevalence of anti-PvMSP-119 IgG increased with age and no statistically significant difference was detected between the sexes. The reversible catalytic model indicated that the seropositive conversion rate and seronegative reversion rate were 0.0042, 0.0034, 0.0032 and 0.0024, 0.0004, 0.0065 in the first-, second-line-of-defense area and total areas, respectively, and the fitted value did not differ significantly from the observed value (P > 0.1). Although this study found the prevalence of antibody-positive subjects and the seroconversion rate in this post-elimination setting were lower than that in transmission setting, the population still had an exposure risk. Serological surveillance should be considered in post-elimination settings to provide valuable information with which to evaluate the risk of malaria re-establishment.

⚠️ This is an automatic machine translation with an accuracy of 90-95%

Translated Description (Arabic)

تم إعلان الصين خالية من الملاريا في يونيو 2021. في بيئة ما بعد القضاء على الملاريا، تعد المراقبة اليقظة ضرورية للحفاظ على حالة خالية من الملاريا. تم الاعتراف بالمراقبة المصلية كأداة فعالة لتقييم مستويات المناعة ومخاطر التعرض لدى السكان. في هذه الدراسة، تم إجراء مسح مصلي مقطعي في مقاطعة ينغجيانغ، الصين، في أغسطس- سبتمبر 2021. كانت مواقع الدراسة عبارة عن قرى على طول الحدود مع ميانمار، والتي لا يوجد بها انتقال محلي منذ آخر حالة من السكان الأصليين تم تسجيلها في عام 2016. تم تسجيل ما مجموعه 923 مشاركًا من ست قرى. كان معظمهم أكبر من 36 عامًا (56.12 ٪) و 12.46 ٪ (115/923) من المشاركين عانوا من عدوى الملاريا مرة واحدة على الأقل. تم استخدام اختبار قائم على الخرز المغناطيسي لاختبار الأجسام المضادة ضد مستضد المتصورة النشيطة PvMSP -119 لتقييم انتشار الأجسام المضادة الإيجابية. تم استخدام نموذج تحفيزي قابل للعكس لتقييم مخاطر التعرض. كان معدل انتشار مضاد PvMSP -119 IgG 12.84 ٪ [فاصل ثقة 95 ٪ (CI): 9.22 ٪-16.47 ٪]، 13.93 ٪ (95 ٪ CI: 10.11 ٪ -17.74 ٪)، و 3.57 ٪ (95 ٪ CI: 1.40 ٪ -5.75 ٪) في ثلاثة مجالات مختلفة لخط الدفاع، والتي اختلفت بشكل كبير (P < 0.0001). زاد انتشار الغلوبولين المناعي G المضاد لـ PvMSP -119 مع تقدم العمر ولم يتم اكتشاف أي فرق ذي دلالة إحصائية بين الجنسين. أشار النموذج التحفيزي القابل للعكس إلى أن معدل التحويل الإيجابي المصلي ومعدل الانعكاس السلبي المصلي كانا 0.0042 و 0.0034 و 0.0032 و 0.0024 و 0.0004 و 0.0065 في منطقة خط الدفاع الأول والثاني والمساحات الإجمالية، على التوالي، ولم تختلف القيمة المجهزة اختلافًا كبيرًا عن القيمة المرصودة (P > 0.1). على الرغم من أن هذه الدراسة وجدت أن انتشار الموضوعات الإيجابية للأجسام المضادة ومعدل الانقلاب المصلي في بيئة ما بعد القضاء كانت أقل من تلك الموجودة في بيئة الانتقال، إلا أن السكان لا يزالون معرضين لخطر التعرض. وينبغي النظر في المراقبة المصلية في بيئات ما بعد القضاء على الملاريا لتوفير معلومات قيمة يمكن من خلالها تقييم خطر إعادة انتشار الملاريا.

Translated Description (English)

China was declared malaria free in June 2021. In the post-elimination setting, vigilant surveillance is essential to sustain malaria free status. Serological surveillance has been recognized as an efficient tool for assessing the immunity levels and exposure risk in a population. In this study, a cross-sectional serological survey was conducted in Yingjiang County, China, in August-September, 2021. The study sites were villages along the borders with Myanmar, which have no local transmission since the last indigenous case registered in 2016. A total of 923 participants from six villages were enrolled. The majority were aged > 36 years (56.12%) and 12.46% (115/923) participants had experienced malaria infection at least once. A magnetic-bead-based assay was used to test antibodies against Plasmodium vivax antigen PvMSP-119 to evaluate the prevalence of antibody positive subjects. A reversible catalytic model was used to assess the risk of exposure. The prevalence of anti-PvMSP-119 IgG was 12.84% [95% confidence interval (CI): 9.22%-16.47%], 13.93% (95% CI: 10.11% -17.74%), and 3.57% (95% CI: 1.40%-5.75%) in three different line-of-defense areas, which differed significantly (P < 0.0001). The prevalence of anti-PvMSP-119 IgG increased with age and no statistically significant difference was detected between the sexes. The reversible catalytic model indicated that the seropositive conversion rate and seronegative reversion rate were 0.0042, 0.0034, 0.0032 and 0.0024, 0.0004, 0.0065 in the first-, second-line-of-defense area and total areas, respectively, and the fitted value did not differ significantly from the observed value (P > 0.1). Although this study found the prevalence of antibody-positive subjects and the seroconversion rate in this post-elimination setting were lower than that in transmission setting, the population still had an exposure risk. Serological surveillance should be considered in post-elimination settings to provide valuable information with which to evaluate the risk of malaria re-establishment.

Translated Description (French)

China was declarated malaria free in June of 2021. In the post-élimination setting, vigilant surveillance is essential to sustain malaria free status. Serological surveillance has been recognized as an efficient tool for assessing the immunity levels and exposure risk in a population. In this study, a cross-sectional serological survey was conducted in Yingjiang County, China, in August-September, 2021. The study sites were villages along the borders with Myanmar, which have no local transmission since the last indigenous case registered in 2016. A total of 923 participants from six villages were enrolled. The majority was aged > 36 years (56.12%) and 12.46% (115/923) participants had experienced malaria infection at least once. A magnetic- bead-based assay was used to test antibodies against Plasmodium vivax antigen PvMSP-119 to evaluate the prevalence of antibody positive subjects. A réversible catalytic model was used to assess the risk of exposure. La prévalence de l'anti-PvMSP-119 IgG était de 12,84 % [intervalle de confiance à 95 % (CI) : 9,22 % -16,47 %], 13,93 % (IC à 95 % : 10,11 % -17,74 %) et 3,57 % (IC à 95 % : 1,40 % -5,75 %) dans les trois zones de lignes de défense différentes, qui différaient significativement (P < 0,0001). La prévalence de l'anti-PvMSP-119 IgG augmentée avec l'âge et non statistiquement significative différence détectée entre les sexes. The réversible catalytic model indicated that the seropositive conversion rate and seronegative reversion rate were 0.0042, 0.0034, 0.0032 and 0.0024, 0.0004, 0.0065 in the first, second-line-of-defense area and total areas, respectively, and the fitted value did not differently from the observéd value (P > 0.1). Although this study found the prevalence of antibody-positive subjects and the seroconversion rate in this post-elimination setting were lower than that in transmission setting, the population still had an exposure risk. Serological surveillance should be considered in post-elimination settings to provide valuable information with which to evaluate the risk of malaria re-establishment.

Translated Description (Spanish)

China was declared malaria free in June of 2021. In the post-elimination setting, vigilant surveillance is essential to sustain malaria free status. Serological surveillance has been recognized as an efficient tool for assessing the immunity levels and exposure risk in a population. In this study, a cross-sectional serological survey was conducted in Yingjiang County, China, in August-September, 2021. The study sites were villages along the borders with Myanmar, which have no local transmission since the last indigenous case registered in 2016. A total of 923 participants from six villages were enrolled. The majority was aged > 36 years (56.12%) and 12.46% (115/923) participants had experienced malaria infection at least once. A magnetic- bead-based assay was used to test antibodies against Plasmodium vivax antigen PvMSP-119 to evaluate the prevalence of antibody positive subjects. A reversible catalytic model was used to assess the risk of exposure. The prevalence of anti-PvMSP-119 IgG was 12.84% [95% confidence interval (CI): 9.22%-16.47%], 13.93% (95% CI: 10.11%-17.74%), and 3.57% (95% CI: 1.40%-5.75%) in three different line-of-defense areas, which differed significantly (P < 0.0001). The prevalence of anti-PvMSP-119 IgG increased with age and no statistically significant difference was detected between the sexes. The reversible catalytic model indicated that the seropositive conversion rate and seronegative reversion rate were 0.0042, 0.0034, 0.0032 and 0.0024, 0.0004, 0.0065 in the first-, second-line-of-defense area and total areas, respectively, and the fitted value did not differficantly from the observed value (P > 0.1). Although this study found the prevalence of antibody-positive subjects and the seroconversion rate in this post-elimination setting were lower than that in transmission setting, the population still had an exposure risk. Serological surveillance should be considered in post-elimination settings to provide valuable information with which to evaluate the risk of malaria re-establishment.

Files

pdf.pdf

Files (1.4 MB)

⚠️ Please wait a few minutes before your translated files are ready ⚠️ Note: Some files might be protected thus translations might not work.
Name Size Download all
md5:39d6aab7325d3ebf8d0fb3094a392369
1.4 MB
Preview Download

Additional details

Additional titles

Translated title (Arabic)
المراقبة المصلية لمخاطر التعرض المحتملة للبلازموديوم النشيط في بيئة ما بعد الاستئصال
Translated title (English)
Serological surveillance on potential Plasmodium vivax exposure risk in a post-elimination setting
Translated title (French)
Surveillance sérologique sur les risques potentiels d'exposition au plasma vivax dans un réglage post-élimination
Translated title (Spanish)
Serological surveillance on potential Plasmodium vivax exposure risk in a post-elimination setting

Identifiers

Other
https://openalex.org/W4323665348
DOI
10.3389/fcimb.2023.1132917

GreSIS Basics Section

Is Global South Knowledge
Yes
Country
China

References

  • https://openalex.org/W1018736814
  • https://openalex.org/W1777998635
  • https://openalex.org/W1892986689
  • https://openalex.org/W1979915824
  • https://openalex.org/W1992094719
  • https://openalex.org/W2001231633
  • https://openalex.org/W2048555355
  • https://openalex.org/W2068830954
  • https://openalex.org/W2074801575
  • https://openalex.org/W2081354450
  • https://openalex.org/W2099551104
  • https://openalex.org/W2102629874
  • https://openalex.org/W2109483062
  • https://openalex.org/W2132409323
  • https://openalex.org/W2133230011
  • https://openalex.org/W2144023590
  • https://openalex.org/W2156575724
  • https://openalex.org/W2158823754
  • https://openalex.org/W2167091406
  • https://openalex.org/W2169195671
  • https://openalex.org/W2216668384
  • https://openalex.org/W2237376292
  • https://openalex.org/W2428247348
  • https://openalex.org/W2490020627
  • https://openalex.org/W2533007924
  • https://openalex.org/W2571528696
  • https://openalex.org/W2612334930
  • https://openalex.org/W2892349373
  • https://openalex.org/W2955203339
  • https://openalex.org/W2993325277
  • https://openalex.org/W3163456135
  • https://openalex.org/W3164243030
  • https://openalex.org/W3178596872
  • https://openalex.org/W3206351883
  • https://openalex.org/W4200099825
  • https://openalex.org/W4214914212
  • https://openalex.org/W4287377047